Literature DB >> 23594983

[Adherence to and satisfaction with oral outpatient thromboembolism prophylaxis compared to parenteral: SALTO study].

L Peidro-Garcés1, R Otero-Fernandez, L Lozano-Lizarraga.   

Abstract

INTRODUCTION: Prolongation of drug-based thromboembolism prophylaxis after discharge from hospital is clearly recommended following total hip and knee replacement. The aim of this study was to evaluate and compare adherence to and satisfaction with outpatient thromboembolism prophylaxis (by injection and oral) under routine clinical practice conditions. MATERIAL AND
METHOD: We analysed two consecutive cohorts of patients (480 and 366, respectively) who had undergone total hip or knee replacement surgery in 120 Spanish hospitals, and were prescribed outpatient thromboembolism prophylaxis, by injection and orally, respectively. Information on adherence to and satisfaction with both treatments, sociodemographic data and treatment compliance was collected using specific questionnaires.
RESULTS: The drop-out rate (9.49 vs. 4.14%), general satisfaction (37 vs. 83.38%), and the TSQM satisfaction scale were better in the oral prophylaxis cohort and, although the differences between the two routes of administration were not significant, treatment compliance was also better in the oral cohort (Morisky-Green test: 53.49 vs. 59.05%).
CONCLUSIONS: Adherence to and satisfaction with the oral thromboembolism prophylaxis were better than for prophylaxis by injection in the context of outpatient prolongation. Nevertheless, suboptimal treatment compliance was found in both cohorts, which could result in lack of efficacy of the prophylaxis. Both patients and doctors have to be made aware of the importance of post-discharge extension of thromboprophylaxis in orthopaedic surgery with high thrombotic risk. Moreover, strategies should be developed to encourage compliance.
Copyright © 2012 SECOT. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23594983     DOI: 10.1016/j.recot.2012.10.009

Source DB:  PubMed          Journal:  Rev Esp Cir Ortop Traumatol        ISSN: 1888-4415


  5 in total

1.  Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.

Authors:  M Farzan Rashid; Terri L Jackson; Jheanell A Morgan; Franklin A Dwyer; Beth A Schrope; John A Chabot; Michael D Kluger
Journal:  J Gastrointest Surg       Date:  2018-09-05       Impact factor: 3.452

2.  Patient's compliance is a contributor to failure of extended antithrombotic prophylaxis in colorectal surgery: prospective cohort study.

Authors:  Carlos Cordova-Cassia; Daniel Wong; Mary B Cotter; Thomas E Cataldo; Vitaliy Y Poylin
Journal:  Surg Endosc       Date:  2021-01-25       Impact factor: 4.584

3.  The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery.

Authors:  Yuan Gao; Anhua Long; Zongyan Xie; Yutong Meng; Jing Tan; Houchen Lv; Licheng Zhang; Lihai Zhang; Peifu Tang
Journal:  Springerplus       Date:  2016-08-18

4.  Satisfaction with and adherence to warfarin treatment: A cross-sectional study among Sudanese patients.

Authors:  Tarig Yousif Mohamed Eltayeb; Malik Suliman Mohamed; Abubaker Ibrahim Elbur; Ahmed Sayed Ahmed Elsayed
Journal:  J Saudi Heart Assoc       Date:  2016-10-29

5.  Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin.

Authors:  Bryce E Haac; Nathan N O'Hara; Theodore T Manson; Gerard P Slobogean; Renan C Castillo; Robert V O'Toole; Deborah M Stein
Journal:  OTA Int       Date:  2021-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.